These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21636566)

  • 1. Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study.
    Julian CG; Subudhi AW; Wilson MJ; Dimmen AC; Pecha T; Roach RC
    J Appl Physiol (1985); 2011 Aug; 111(2):392-9. PubMed ID: 21636566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia.
    Song TT; Bi YH; Gao YQ; Huang R; Hao K; Xu G; Tang JW; Ma ZQ; Kong FP; Coote JH; Chen XQ; Du JZ
    J Neuroinflammation; 2016 Mar; 13(1):63. PubMed ID: 26968975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal analysis of the effects of dexamethasone on high-altitude cerebral oedema: protocol for a pilot study.
    Fisher O; Benson RA; Wayte S; Kimani PK; Hutchinson C; Imray CHE
    Trials; 2019 Oct; 20(1):604. PubMed ID: 31651350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Cytokines at High Altitude: Lack of Effect of Ibuprofen on Acute Mountain Sickness, Physiological Variables, or Cytokine Levels.
    Lundeberg J; Feiner JR; Schober A; Sall JW; Eilers H; Bickler PE
    High Alt Med Biol; 2018 Sep; 19(3):249-258. PubMed ID: 29924642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
    J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute mountain sickness score and hypoxemia.
    Hussain MM; Aslam M; Khan Z
    J Pak Med Assoc; 2001 May; 51(5):173-9. PubMed ID: 11467238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute mountain sickness and high-altitude pulmonary edema. How to protect the mountain climber from the effects of the "altitude haze"].
    Dehnert Ch; Schneider M; Mairbäurl H; Bärtsch P
    MMW Fortschr Med; 2003 Feb; 145(8):33-5. PubMed ID: 12661438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
    Ritchie ND; Baggott AV; Andrew Todd WT
    J Travel Med; 2012; 19(5):298-307. PubMed ID: 22943270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
    Kayser B; Hulsebosch R; Bosch F
    High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
    High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
    Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
    Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia.
    Subudhi AW; Dimmen AC; Julian CG; Wilson MJ; Panerai RB; Roach RC
    J Appl Physiol (1985); 2011 May; 110(5):1219-25. PubMed ID: 21393464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined methazolamide and theophylline improves oxygen saturation but not exercise performance or altitude illness in acute hypobaric hypoxia.
    Subudhi AW; Evero O; Reitinger J; Davis C; Gronewold J; Nichols AJ; Van-Houten SJ; Roach RC
    Exp Physiol; 2021 Jan; 106(1):117-125. PubMed ID: 32363610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploratory proteomic analysis of hypobaric hypoxia and acute mountain sickness in humans.
    Julian CG; Subudhi AW; Hill RC; Wilson MJ; Dimmen AC; Hansen KC; Roach RC
    J Appl Physiol (1985); 2014 Apr; 116(7):937-44. PubMed ID: 24265281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2, IL-17A and TNF-α hold potential as biomarkers for predicting acute mountain sickness prior to ascent.
    Guo H; Wang Q; Li T; Sun W; Chen J; Wang C; Wang C
    Cytokine; 2024 Sep; 181():156694. PubMed ID: 39024679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute mountain sickness: controversies and advances.
    Bartsch P; Bailey DM; Berger MM; Knauth M; Baumgartner RW
    High Alt Med Biol; 2004; 5(2):110-24. PubMed ID: 15265333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-altitude headache and acute mountain sickness.
    Carod-Artal FJ
    Neurologia; 2014; 29(9):533-40. PubMed ID: 22703629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
    Carlsten C; Swenson ER; Ruoss S
    High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness.
    Nourkami-Tutdibi N; Küllmer J; Dietrich S; Monz D; Zemlin M; Tutdibi E
    Front Physiol; 2023; 14():1083808. PubMed ID: 37064896
    [No Abstract]   [Full Text] [Related]  

  • 20. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.